Martin J D, Hähnel R, McCartney A J, De Klerk N
Gynecol Oncol. 1986 Mar;23(3):329-35. doi: 10.1016/0090-8258(86)90134-4.
The prognostic value of estrogen receptors (ER) and progesterone receptors (PR) was studied in 246 women with primary carcinoma of the uterine cervix. In addition to the receptor status information on tumor stage, histological type, age at operation, and menopausal status was recorded and analyzed. If the patient died the cause of death was ascertained. The median survival time for the 97 patients who died was 15 months and the survivors were followed for an average of 34 months. The survival curve was compared with an age, sex, and year of death matched West-Australian population. The survival curves for patients with ER+ or ER- and PR+ or PR- tumors were virtually indistinguishable. Overall survival in patients with cervical carcinoma is not influenced by the receptor status or the receptor concentration of the carcinoma.
对246例子宫颈原发性癌女性患者的雌激素受体(ER)和孕激素受体(PR)的预后价值进行了研究。除了受体状态外,还记录并分析了肿瘤分期、组织学类型、手术年龄和绝经状态等信息。如果患者死亡,则确定死亡原因。97例死亡患者的中位生存时间为15个月,对存活患者平均随访34个月。将生存曲线与年龄、性别和死亡年份相匹配的西澳大利亚人群进行比较。ER+或ER-以及PR+或PR-肿瘤患者的生存曲线几乎没有差异。子宫颈癌患者的总体生存不受癌组织受体状态或受体浓度的影响。